PPARG and endometriosis: PPARγ agonists can not only modulate glucose and lipid metabolism but also have anti-inflammatory effects, in an experimental endometriosis rat model, PPARγ agonists rosigliotazone treatment or no medication control were given for 4 weeks, the size and weight of endometriotic lesions were significantly decreased in rosiglitazone-treated groups compared with the control (41).